September's issue of Regulatory Rapporteur takes a closer look at the regulatory framework in the MENA/Africa region. Read the editorial "Streamlining regulatory processes across the MENA region". https://t.co/5pjkoBlQwZ #regulatoryaffairs#MENA
Very sad news: The European Medicines Agency mourns the passing of Jordi Llinares Garcia, Head of Research and Innovation at the EMA https://t.co/SHyESWL6J2 via @EMA_News
Regulatory affairs employers can claim £3000 for recruiting new apprentices before Nov 2021 (England only). If you need to increase reg affairs capacity in your organisation the apprenticeship could be the solution. Next deadline for applications 6 Sept https://t.co/yDXQVxeHgU
Next month's Regulatory Rapporteur looks at the regulatory considerations in pain management for humans and animals. Read the editorial "How regulatory efforts contribute to optimisation of pain treatments" https://t.co/Ltq1mbfOPi #regulatoryaffairs#veterinarymedicine
Since the first #vaccines against anthrax & rabies were developed in the late 19th century, #AnimalHealth innovations have greatly evolved over the centuries to ensure vets, farmers and all animal owners have a range of solutions for protecting animal health.
💉💊🔬🌡️🧬🧫📱
There is currently insufficient evidence that inhaled corticosteroids are beneficial for people with COVID-19 who are not in hospital:https://t.co/yfZN5jWAkK
The latest issue of Regulatory Rapporteur will look at #data#transparency and the challenges of presenting clinical trial information in a comprehensible format. Read the editorial "Clinical data transparency in the digital era" https://t.co/SrjLwkEAUV #regulatoryaffairs
Journals risk being used in place of regulators when they publish studies of novel vaccines that have not yet been authorised by a major regulator @DoctorChrisVT unpicks the story of the Sputnik V vaccine https://t.co/lYf7l0lXcy
In the age of COVID-19, OTC medicines often get overlooked, but it plays a vital role in keeping citizens healthy when access to healthcare is limited due to lockdowns. Read the editorial "Building the OTC arsenal to improve self-care" https://t.co/YUSP7piXSM #OTCmarket#OTC
Here, @hVIVO_UK’s VP Regulatory Affairs, Bruno Speder discusses Rolling Reviews: a useful tool to speed up the regulatory review process in @TOPRANEWS Regulatory Rappeatour
https://t.co/BWT6QjhM69
How do you advertise the #green credentials of a product or business? Huw Cookson and I have taken a look at the key issues with making green claims and some likely changes on the horizon.
https://t.co/iOoVn3eoNV #greenwashing#healthcare@TOPRANEWS
The April issue of Regulatory Rapporteur will examine nonclinical studies. Read the editorial: "In the midst of another industrial revolution" https://t.co/bfFCierBgP #regulatoryaffairs#nonclinical